Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug search continues.

Michael Le Page

    New Scientist (1971)
    |June 11, 2020
    PubMed
    Summary
    This summary is machine-generated.

    New medicines show promise, but evidence is lacking to confirm their effectiveness for patients who need them most. Further research is crucial to validate these potential treatments.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same authorSame journal

    Covid-19 vaccine tweak could better tackle today's variants.

    New scientist (1971)·2023
    Same author

    Coronavirus mutations offer a new insight into evolution.

    New scientist (1971)·2023
    Same author

    The next covid-19 vaccines.

    New scientist (1971)·2023
    Same author

    Monkeypox unnoticed?

    New scientist (1971)·2022
    Same author

    Mutation-inducing drugs could raise virus dangers.

    New scientist (1971)·2022
    Same author

    Could vaccines end the pandemic?

    New scientist (1971)·2022

    Area of Science:

    • Pharmacology and Therapeutics
    • Clinical Medicine

    Background:

    • Significant investment is being made in developing novel pharmaceutical agents.
    • There is a growing pipeline of drugs showing potential in early-stage research.

    Purpose of the Study:

    • To critically evaluate the evidence supporting the efficacy of newly developed medicines.
    • To determine if promising drugs translate into meaningful clinical benefits for patients.

    Main Methods:

    • Systematic review of clinical trial data.
    • Analysis of real-world evidence and patient outcomes.
    • Assessment of drug safety and tolerability profiles.

    Main Results:

    • Many new drugs demonstrate preliminary efficacy in controlled settings.

    Related Experiment Videos

  • Limited data exists on long-term benefits and effectiveness in diverse patient populations.
  • Potential for off-target effects and unexpected adverse events requires further investigation.

    • Conclusions:

    • While enthusiasm for new medicines is high, robust clinical validation is essential.
    • More research is needed to confirm the real-world benefits of promising drug candidates.
    • Ensuring equitable access to effective treatments for all patients remains a challenge.